Actualités Allspring Smid Core ETF - ASCE | Actions American Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Duncan Technology Group Completes Reverse Merger With Ascentia Biomedical Corporation

NEW YORK, Dec. 7 /PRNewswire-FirstCall/ -- Ascentia Biomedical Corporation ("Ascentia") (OTC:ASCE) today announced that, effective November 28...

Ascentia Biomedical Announces a Shift to Biomedical Arbitrage and Development to Achieve Profitability

BELLEVUE, Wash., May 30 /PRNewswire-FirstCall/ -- Ascentia Biomedical Corporation (OTC Pink Sheets: ASCE), a leading researcher and developer of...

Ascentia Biomedical Corporation Announces the Addition of Dr. Philip Mease, an Internationally Recognized Rheumatologist, to the

BELLEVUE, Wash., Sept. 30 /PRNewswire-FirstCall/ -- Ascentia Biomedical Corporation (OTC Pink Sheets: ASCE), a leading researcher and developer...

Ascentia Biomedical Receives $1 Million Funding Commitment to Support Continued Research and Organizational Growth

BELLEVUE, Wash., Sept. 14 /PRNewswire-FirstCall/ -- Ascentia Biomedical Corporation (OTC Pink Sheets: ASCE), a leading researcher and developer...

Ascentia Biomedical Corporation Further Defines Option Agreement With University of Washington for Anti-Cancer Compound

BELLEVUE, Wash., Aug. 31 /PRNewswire-FirstCall/ -- Ascentia Biomedical Corporation (OTC Pink Sheets: ASCE), a leading researcher and developer...

Ascentia Biomedical Corporation Announces Option Agreement With University of Washington for Anti-Cancer Compound

BELLEVUE, Wash., Aug. 15 /PRNewswire-FirstCall/ -- Ascentia Biomedical Corporation (OTC Pink Sheets: ASCE), a leading researcher and developer...

Ascentia Biomedical Corporation Announces New Laboratory and Office Space; Adds Dr. Peter Klein, Renown Pharmaceutical Chemist t

Ascentia Biomedical Corporation Announces New Laboratory and Office Space; Adds Dr. Peter Klein, Renown Pharmaceutical Chemist to Its Staff...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Allspring Smid Core ETF (ASCE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Allspring Smid Core ETF (ASCE) Actualités

Duncan Technology Group Completes Reverse Merger With Ascentia Biomedical Corporation

Ascentia Biomedical Announces a Shift to Biomedical Arbitrage and Development to Achieve Profitability

Ascentia Biomedical Corporation Announces the Addition of Dr. Philip Mease, an Internationally Recognized Rheumatologist, to the

Ascentia Biomedical Receives $1 Million Funding Commitment to Support Continued Research and Organizational Growth

Ascentia Biomedical Corporation Further Defines Option Agreement With University of Washington for Anti-Cancer Compound

Ascentia Biomedical Corporation Announces Option Agreement With University of Washington for Anti-Cancer Compound

Ascentia Biomedical Corporation Announces New Laboratory and Office Space; Adds Dr. Peter Klein, Renown Pharmaceutical Chemist t

/C O R R E C T I O N -- Ascentia Biomedical Corporation/

Ascentia Biomedical Corporation Announces Its High Profile Scientific Advisory Board

Ascentia Biomedical Corporation Begins Trading on OTC Pink Sheets Under Ticker Symbol 'ASCE'

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Allspring Smid Core ETF (ASCE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Allspring Smid Core ETF (ASCE) Actualités

Duncan Technology Group Completes Reverse Merger With Ascentia Biomedical Corporation

Ascentia Biomedical Announces a Shift to Biomedical Arbitrage and Development to Achieve Profitability

Ascentia Biomedical Corporation Announces the Addition of Dr. Philip Mease, an Internationally Recognized Rheumatologist, to the

Ascentia Biomedical Receives $1 Million Funding Commitment to Support Continued Research and Organizational Growth

Ascentia Biomedical Corporation Further Defines Option Agreement With University of Washington for Anti-Cancer Compound

Ascentia Biomedical Corporation Announces Option Agreement With University of Washington for Anti-Cancer Compound

Ascentia Biomedical Corporation Announces New Laboratory and Office Space; Adds Dr. Peter Klein, Renown Pharmaceutical Chemist t

/C O R R E C T I O N -- Ascentia Biomedical Corporation/

Ascentia Biomedical Corporation Announces Its High Profile Scientific Advisory Board

Ascentia Biomedical Corporation Begins Trading on OTC Pink Sheets Under Ticker Symbol 'ASCE'

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités